| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |